Evidence map›Paper›PMID 33376609›Full record

ArticleProstate cancer2020

Clinical, Histopathological, and Prognostic Characteristics of Patients with Prostate Cancer in Lubumbashi, Democratic Republic of Congo.

Pitchou Mukaz Mbey, Olivier Mukuku, Willy Kalau Arung, Guylain Kitoko Tengu, Nasser Lubosha Amisi, Véronique Kabila Kyabu, Etienne Fwamba Koshe Odimba, François Katombe Tshilombo

Abstract read
In one paragraph

Article in Prostate cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pitchou Mukaz MbeyDepartment of Surgery, Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo.
Olivier MukukuInstitut Supérieur des Techniques Médicales, Lubumbashi, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0001-6902-7023
Willy Kalau ArungDepartment of Surgery, Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo.
Guylain Kitoko TenguCentre Médical Baraka, Lubumbashi, Democratic Republic of the Congo.
Nasser Lubosha AmisiHôpital Militaire de Garnison de Lubumbashi, Lubumbashi, Democratic Republic of the Congo.
Véronique Kabila KyabuDepartment of Histopathology, Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo.
Etienne Fwamba Koshe OdimbaDepartment of Surgery, Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo.
François Katombe TshilomboDepartment of Surgery, Faculty of Medicine, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProstate cancer is currently a public health problem with a frequency that varies from country to country. This study aims to describe the epidemiological, clinical, and histopathological and outcome features of prostate cancer in Lubumbashi in the Democratic Republic of Congo. MATERIALS AND

methodsThis was a descriptive longitudinal study of patients diagnosed with prostate cancer at the University Clinics of Lubumbashi. The study period was 3 years (2017 to 2019). Parameters studied were age and clinical, biological (PSA level, prostatic specific antigen), histopathological, and outcome features.

resultsThe mean age of patients was 68.7 years (range: 47 and 90 years). The 60 to 69 age group was the most affected (43.18%). Elderly subjects (≥60 years old) represented 89.77% of the cases (

conclusionProstate cancer is frequent and has a poor outcome in our country. The establishment of an individual screening policy would be an undeniable advantage in improving the prognosis.

Identifiers

PMID33376609
PMCPMC7746450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.